Editer l'article
Suivre ce blog
Administration
Connexion
+
Créer mon blog
Publicité
Neuroptis Dry Eye Project with ML 7 (Myosin Light Chain Inhibitor)
Home
ML7 Project
Tests Results
Patents
News
Financing
Publications
Clinical Trials
Neuroptis Dry Eye Project with ML 7 (Myosin Light Chain Inhibitor)
>
Science
>
VIDEO: New paradigm for meibomian gland evaluation
6 août 2015
VIDEO: New paradigm for meibomian gland evaluation
VIDEO: New paradigm for meibomian gland evaluation
SHIRE ACQUIRES FORESIGHT BIOTHERAPEUTICS FOR $300MN
Biphasic force response to iso-velocity stretch in airway smooth muscle.
Vous aimerez aussi :
NEW PUBLICATIONS UPTO DECEMBER 18TH 2015
NEW PUBLICATIONS UPTO NOV. 27TH 2015
NEW PUBLICATIONS UPTO OCT. 31ST 2015
NEW PUBLICATIONS UPTO OCT. 24TH 2015
Publicité
Publicité
Commentaires
Recherche
Publicité
Neuroptis Dry Eye Project with ML 7 (Myosin Light Chain Inhibitor)
ML7 - Neuroptis Biotech - MLCK Inhibitor - Dry Eye Syndrome - Glaucoma - Myosin Light Chain Inhibitor - Sécheresse oculaire - Glaucome - Inhibiteur des chaines légères de Myosine.
Accueil du blog
Créer un blog avec CanalBlog
Newsletter
Email
Contacter le propriétaire du blog
Catégories
Dry Eye
Ded
2015
Publications
Ml7
Treatment
Diagnosis
News
Meibomian
Tarsal Glands Meibomius Glands Protection
Tarsal Glands Meibomius Glands Dysfunction
Mlck Inhibitor
New Therapies
Mlck
Tearfilm Quality
2014
Case Control Study
Research
Sjögren's Syndrome
Formulation
Medical Device
Tearscience Website
Clinical Trial
Patents
Animals Efficacy
Biotech Finances
Drug Development
Visiteurs
Depuis la création
33 340
Flux RSS
Publicité